Understand the source comparison
Best Cartalax for Bone Health: Research-Grade Comparison
When evaluating suppliers for bone health research, synthesis method, purity verification, and storage handling separate research-grade peptides from commercial-grade alternatives. Synthesis Method Solid-phase peptide synthesis (SPPS) with sequential amino aci
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- When evaluating suppliers for bone health research, synthesis method, purity verification, and storage handling separate research-grade peptides from commercial-grade alternatives.
- Synthesis Method
- Solid-phase peptide synthesis (SPPS) with sequential amino acid verification
- Bulk synthesis without per-step verification
- SPPS with verification minimises deletion sequences and coupling errors. Critical for tripeptides where one substitution destroys bioactivity
- Purity Verification
- HPLC ≥98% + mass spectrometry confirmation (303 Da) + CoA with chromatogram
- HPLC data only, or no independent verification
- MS confirmation is non-negotiable for research. HPLC alone cannot distinguish Cartalax from closely related tripeptides with similar retention times
- Storage and Shipping
- Lyophilised powder, stored at −20°C, shipped with cold packs or dry ice
- Ambient temperature storage and shipping
- Temperature excursions degrade glutamic acid and aspartic acid residues irreversibly. Cold-chain shipping is essential, not optional
- Reconstitution Solvent Included
- Bacteriostatic water (0.9% benzyl alcohol) provided or specified
- No solvent guidance, or recommendation for plain sterile water
- Bacteriostatic water extends post-reconstitution stability to 28 days vs 3–5 days for sterile water. Critical for multi-week protocols
- Batch Consistency
- Small-batch synthesis with per-batch CoA
- Large-batch synthesis with single representative CoA
- Small-batch synthesis allows per-batch testing. Large batches increase the risk that some vials contain degraded or off-specification product
- Regulatory Compliance
- Synthesized in FDA-registered or equivalent facilities under GMP guidelines
- Unknown or unverified synthesis facility
- Regulatory oversight reduces contamination risk and ensures traceability if batch issues arise
- Real Peptides uses small-batch SPPS with exact amino-acid sequencing and third-party MS verification for every Cartalax batch. Each vial ships with cold packs and includes a CoA showing HPLC purity ≥98% and confirmed molecular weight. For researchers who need reproducible results across experiments, this level of quality control is the baseline.